Home > Insider Trading > Bausch Health Companies Inc. > Profile

Bausch Health Companies Inc. (BHC)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

B Amy Wechsler, Director, 2025-04-01
Brett Icahn, Director, 2025-04-01
John Paulson, Director, 2025-04-01
S John Barresi, Svp, Controller & Cao, 2025-03-03
Thomas Appio, Chief Executive Officer, 2025-03-03
Seana Carson, Evp, General Counsel, 2025-03-03
J. Aimee Lenar, Evp, Us Pharma, 2025-02-28
Jean-Jacques Charhon, Evp, Cfo, 2025-02-28
Richard Mulligan, Director, 2024-05-21
A Christian Garcia, Director, 2024-05-21
D. Frank Lee, Director, 2024-05-21
N Robert Power, Director, 2024-05-20
D Steven Miller, Director, 2024-05-20
B Sarah Kavanagh, Director, 2024-05-20
C Russel Robertson, Director, 2024-04-01
George Tom Vadaketh, Evp, Chief Financial Officer, 2023-09-06
Sr. W. Thomas Ross, Director, 2023-05-19
U Richard Schutter De, Director, 2023-04-04
N Argeris Karabelas, Director, 2022-06-28
C Joseph Papa, Director, 2022-05-13
Robert Spurr, President, U.s. Businesses, 2022-05-13
Christina Ackermann, Evp And General Counsel, 2022-03-11
F Joseph Gordon, Pres&Co-Head Bausch&Lomb/Int'l, 2022-03-10
Frederick Munsch, Svp, Controller And Cao, 2022-03-07
Sam Eldessouky, Evp & Chief Financial Officer, 2022-03-07
C. Andrew Eschenbach Von, Director, 2021-08-09
Valueact Capital Management, Llc, Director, Other, 2021-05-03
Valueact Capital Management, L.p., Director, Other, 2021-05-03
Va Partners I, Llc, Director, Other, 2021-05-03
Valueact Holdings Gp, Llc, Director, Other, 2021-05-03
Valueact Holdings, L.p., Director, Other, 2021-05-03
Valueact Capital Master Fund, L.p., Director, Other, 2021-05-03
Robert David Hale, Director, Other, 2021-05-03
Valueact Holdings Ii, L.p., Director, Other, 2021-05-03
Paul Herendeen, Evp And Cfo, 2021-03-11
D. William Humphries, President, Ortho-Dermatologics, 2020-12-08
Valueact Co-Invest Master Fund, L.p., Director, Other, 2020-06-10
C. Mark Mckenna, President, Salix, 2019-08-21
N Fredric Eshelman, Director, 2018-05-03
Pershing Square Capital Management, L.p., Other, 2017-05-03
Ps Management Gp, Llc, Other, 2017-05-03
A William Ackman, Other, 2017-05-03
Stephen Fraidin, Other, 2017-05-03
Alexander Robert Ingram, Director, 2017-04-04
Clem Anne Whitaker, Evp, Company Group Chairman, 2016-12-20
Ari Kellen, Evp, Company Group Chairman, 2016-12-07
L. Robert Rosiello, Evp, Corp Dev & Strategy, 2016-12-07
Mason G Morfit, Director, Other, 2016-05-11
Ann Norma Provencio, Director, 2016-05-04
Theo Kyriazi Melas, Director, 2016-05-04
Harold Ronald Farmer, Director, 2016-05-04
Bradley Howard Schiller, Chairman And Ceo, 2016-02-22
Michael J. Pearson, Chief Executive Officer, 2016-01-06
Debora Jorn, Evp, Company Group Chairman, 2015-11-24
Roswell Robert Chai-Onn, Evp, Clo, General Counsel, 2015-10-22
Pavel Mirovsky, Evp, Pres. & Gm Valeant Emena, 2015-06-24
M. Brian Stolz, Evp, Administration & Chco, 2015-06-24
W Jeffrey Ubben, Director, Other, 2015-06-12
Berghuis Katharine Stevenson, Director, 2015-05-27
Anders Lonner, Director, 2015-05-27
A Colleen Goggins, Director, 2015-05-27
Laizer Kornwasser, Evp, Company Group Chairman, 2015-04-28
Ryan Weldon, Evp, Company Group Chairman, 2014-04-30
Fred Hassan, Director, 2013-09-03
Mark Daniel Wechsler, Evo, Co. Grp. Chmn, Eye Health, 2013-08-14
Susan Hall, Global Head Of R&D, 2013-07-30
Mitchell Lloyd Segal, Director, 2013-06-18
Rajiv Silva De, President And Coo, 2013-01-08
David Jason Hanson, Evp, Company Group Chairman, 2012-12-13
E Laurence Paul, Director, 2012-06-05
Kevin Richard Masterson, Pres. & Coo, Valeant Intl. Bb, 2012-05-14
Jr Walden Philip Loberg, Evp, Interim Cfo, 2011-07-27
Robert Michael Every Van, Director, 2011-05-23
Andrew Mark Durham, Svp Human Resources, 2011-05-13
Michel Chouinard, Coo, Biovail Labs. Intl Srl, 2010-12-27
Mcdowall William Wells, Director, 2010-12-08
Jean Margaret Mulligan, Evp, Cfo, 2010-11-16
Christian Hans Fibiger, Chief Scientific Officer, 2010-10-06
Christine Mayer, Svp, Bta Pharmaceuticals, Inc., 2010-10-06
Frank Potter, Director, 2010-07-07
Randall Louis Tull, Director, 2010-07-07
David Gregory Gubitz, Svp, Corp. Devel. & Gc, 2010-07-07
Gilbert Godin, Evp & Coo, 2010-07-07
W Mark Parrish, Director, 2010-07-06
Spencer John Lanthier, Director, 2010-07-06
H. David Laidley, Director, 2010-07-06
Serge Gouin, Director, 2010-07-06
Paul John Douglas Squires, Director, 2010-07-06

Show All Insiders (88)

Hedge Fund Popularity

Display

Display Share Price

Display Standard Version

Hedge Fund Holdings

Filing Period: Filing is Ongoing

Last updated on May 08, 2025, 4:03 pm based on SEC 13F filings Last update: May 08, 2025, 4:03 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Leucadia National Ian Cumming And Joseph Steinberg	63,359	$409,933	-86%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Miller	$24.17	10,000	Director	10,000	2021-11-30	Filing
Miller	$24.24	50,000	Director	60,780	2021-11-30	Filing
Von	$25.94	1,400	Director	38,647	2021-08-05	Filing
De	$25.01	10,000	Director	317,109	2021-08-04	Filing
Valueact	$19.24	948,353	Director, Other	17,931,594	2020-06-05	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Carson	$8.35	440	Officer	433,066	2024-12-02	Filing
Carson	$6.21	13,370	Officer	435,198	2024-09-06	Filing
Carson	$9.80	133	Officer	499,905	2024-03-04	Filing
Carson	$9.80	1,561	Officer	500,038	2024-03-04	Filing
Carson	$9.80	199	Officer	501,599	2024-03-04	Filing

Institutional Investors' Holdings

Filing Period: Filing is Ongoing

No.	Name	Shares	Value	% Port
1.	Private Management Group Inc	1,439,426	$9,313,086	0.34%
2.	Td Asset Management Inc	847,676	$5,495,096	0.01%
3.	Readystate Asset Management Lp	470,761	$3,045,824	0.1%
4.	Fountainhead Am, Llc	371,129	$2,401,205	0.39%
5.	Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management Corp	238,500	$1,546,087	0.01%

News See All

Click here to See All News